Table of Contents 1 Relevant Concept of Alectinib 1.1 Indications of Alectinib 1.2 Development of China’s Alectinib Market 1.3 Governmental Approval of Alectinib in China 1.4 The Impact of COVID-19 on China’s Alectinib Market 2 Sales of Alectinib in China, 2016-2020 2.1 Sales Value 2.1.1 Sales Value in China 2.1.2 Sales Value in China by Region 2.2 Sales Volume 2.2.1 Sales Volume in China 2.2.2 Sales Volume in China by Region 2.3 Sales of Alectinib in China by Dosage Form, 2016-2020 2.3.1 Capsules 2.3.2 Other Dosage Forms 3 Analysis of Major Alectinib Manufacturers in China, 2020 3.1 Analysis of Market Share 3.1.1 Market Share of Manufacturers by Sales Value 3.1.2 Market Share of Manufacturers by Sales Volume 3.2 Excella GmbH & Co. KG 3.2.1 Company Profile 3.2.2 Sales of Alectinib in China 4 Sales Price of Alectinib of Different Companies in China, 2020-2021 4.1 Excella GmbH & Co. KG (Alecensa®) 4.2 Others 5 Prospects of China’s Alectinib Market, 2021-2025 5.1 Influencing Factors for the Market Development 5.1.1 The Impact of COVID-19 on the Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information of Alectinib in China Chart Sales Value of Alectinib in China, 2016-2020 Chart Sales Volume of Alectinib in China, 2016-2020 Chart Sales Value of Alectinib Capsules in China, 2016-2020 Chart Sales Value and Volume of Alectinib (of Excella GmbH & Co. KG) in China, 2016-2020 Chart Sales Price of Alecensa (Alectinib of Excella GmbH & Co. KG) in China, 2020 Chart Forecast on Sales Value of Alectinib in China, 2021-2025 Chart Forecast on Sales Volume of Alectinib in China, 2021-2025

1 Excella GmbH & Co. KG (Alecensa®)